Title : Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.

Pub. Date : 2021 May 1

PMID : 33775688






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since NF-kappaB activity is considered to be relatively high in particular when it comes to breast cancer, in the present work, we proposed that the inhibition of NF-kappaB activity can augment and enhance the sensitivity of breast cancer cells to chemotherapy such as doxorubicin (DOX) by virtue of MDR modulation. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
2 Since NF-kappaB activity is considered to be relatively high in particular when it comes to breast cancer, in the present work, we proposed that the inhibition of NF-kappaB activity can augment and enhance the sensitivity of breast cancer cells to chemotherapy such as doxorubicin (DOX) by virtue of MDR modulation. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
3 Since NF-kappaB activity is considered to be relatively high in particular when it comes to breast cancer, in the present work, we proposed that the inhibition of NF-kappaB activity can augment and enhance the sensitivity of breast cancer cells to chemotherapy such as doxorubicin (DOX) by virtue of MDR modulation. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
4 Since NF-kappaB activity is considered to be relatively high in particular when it comes to breast cancer, in the present work, we proposed that the inhibition of NF-kappaB activity can augment and enhance the sensitivity of breast cancer cells to chemotherapy such as doxorubicin (DOX) by virtue of MDR modulation. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
5 Our results demonstrated that the DOX-resistant MCF-7 and MDA-MB-231 clones exhibit higher NF-kappaB (p65) function, which is linked to the upregulated expression of ABCB1 and ABCC1 transporter proteins. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
6 The DOX/NF-kappaB inhibitor combinations hampered NF-kappaB (p65) activation and downregulated MDR efflux transporters" level. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
7 The DOX/NF-kappaB inhibitor combinations hampered NF-kappaB (p65) activation and downregulated MDR efflux transporters" level. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens
8 Breast cancer cell migration was sharply suppressed in cells co-treated with DOX/NF-kappaB inhibitors. Doxorubicin nuclear factor kappa B subunit 1 Homo sapiens